SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Sanofi-Aventis: Click to view the issuer\'s details

Last update : 29/03/2019  >View issuer details

2020.04.06 | 23:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron - HTML (w)

2020.04.06 | 23:00 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce Sanofi finalise la restructuration de l’accord relatif à Praluent® (alirocumab) avec Regeneron - HTML (w)

2020.04.06 | 20:11 | Permanent Information Releases / Operations

English version HTML (w) Mail

puce Sanofi successfully prices taps on outstanding bond issues for EUR 500 million - HTML (w)

2020.04.06 | 20:11 | Permanent Information Releases / Operations

French version HTML (w) Mail

puce Sanofi abonde avec succès des emprunts obligataires pour un montant de 500 millions d’euros - HTML (w)

2020.04.03 | 07:30 | Permanent Information Releases / Notification of availability

English version HTML (w) Mail

puce Sanofi: Availability of the Pre-quarterly Results Communication - HTML (w)

2020.04.03 | 07:30 | Permanent Information Releases / Notification of availability

French version HTML (w) Mail

puce Sanofi: Mise en ligne du document  «Pre-quarterly Results Communication » - HTML (w)

2020.03.27 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19 - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2829